Anaesthesia recommendations for Bullous pemphigoid

Immunology and Microbiology

• Autoantibodies 100%
• Bullous Pemphigoid 100%
• Immunoglobulin A 50%
• Immunosuppressive Drug 50%
• Antigen-Antibody Interaction 50%
• Pemphigoid 50%
• Nasopharynx 50%
• Esophagus 50%
• Inflammatory Cell 50%
• Pemphigus 50%
• Oropharynx 50%
• Intravenous Immunoglobulin 50%
• Staining 50%
• Methotrexate 50%
• Mucosa 50%
• Scar Formation 50%
• Anus 50%
• Autoimmune Disease 50%
• Azathioprine 50%
• Drug Megadose 50%
• Cicatricial Pemphigoid 50%
• Basement Membrane 50%
• Dermatitis 50%

Medicine and Dentistry

• Bullous Pemphigoid 100%
• Diseases 100%
• Cancer 50%
• Haemophilia A 33%
• Autoantibodies 33%
• Disease Course 16%
• Epithelium 16%
• Mucosa 16%
• Drug Megadose 16%
• Bacterial Infection 16%
• Inflammatory Cell 16%
• Larynx 16%
• Esophagus 16%
• Vesicular Rash 16%
• Blister 16%
• Antigen Antibody Reaction 16%
• Tetracycline 16%
• Nasopharynx 16%
• Oropharynx 16%
• Scar Formation 16%
• Azathioprine 16%
• Anus 16%
• Antibiotics 16%
• Niacin 16%
• Bullous Disease 16%
• Basement Membrane Zone 16%
• Dermatitis Herpetiformis 16%
• Epidermolysis Bullosa Acquisita 16%
• Cicatricial Pemphigoid 16%
• Bullous Skin Disease 16%
• Topical Corticosteroid 16%
• Pemphigus 16%
• Autoimmune Disease 16%
• Immunosuppressive Drug 16%
• Methotrexate 16%
• Immunoglobulin A 16%
• Pemphigoid 16%
• Cytotoxic Agent 16%